| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Multiple-dose pharmacokinetics and pharmacodynamics of evogliptin (DA-1229), a novel dipeptidyl peptidase IV inhibitor, in healthy volunteers.
|
Drug Des Devel Ther
|
2014
|
0.84
|
|
2
|
Pharmacokinetics of Second-Line Antituberculosis Drugs after Multiple Administrations in Healthy Volunteers.
|
Antimicrob Agents Chemother
|
2015
|
0.80
|
|
3
|
A fixed-dose combination tablet of gemigliptin and metformin sustained release has comparable pharmacodynamic, pharmacokinetic, and tolerability profiles to separate tablets in healthy subjects.
|
Drug Des Devel Ther
|
2015
|
0.78
|
|
4
|
Comparative steady-state pharmacokinetic study of an extended-release formulation of itopride and its immediate-release reference formulation in healthy volunteers.
|
Drug Des Devel Ther
|
2014
|
0.78
|
|
5
|
Novel nanocrystal formulation of megestrol acetate has improved bioavailability compared with the conventional micronized formulation in the fasting state.
|
Drug Des Devel Ther
|
2014
|
0.78
|
|
6
|
Pharmacokinetics, Safety, and Tolerability of Metformin in Healthy Elderly Subjects.
|
J Clin Pharmacol
|
2016
|
0.78
|
|
7
|
Pharmacokinetic-pharmacodynamic analysis to evaluate the effect of moxifloxacin on QT interval prolongation in healthy Korean male subjects.
|
Drug Des Devel Ther
|
2015
|
0.76
|
|
8
|
Evaluation of the pharmacokinetic and pharmacodynamic drug interactions between cilnidipine and valsartan, in healthy volunteers.
|
Drug Des Devel Ther
|
2014
|
0.75
|
|
9
|
Comparison of the pharmacokinetics and tolerability of HCP1004 (a fixed-dose combination of naproxen and esomeprazole strontium) and VIMOVO® (a marketed fixed-dose combination of naproxen and esomeprazole magnesium) in healthy volunteers.
|
Drug Des Devel Ther
|
2015
|
0.75
|
|
10
|
Pharmacokinetics of the evogliptin/metformin extended-release (5/1,000 mg) fixed-dose combination formulation compared to the corresponding loose combination, and food effect in healthy subjects.
|
Drug Des Devel Ther
|
2016
|
0.75
|
|
11
|
The novel carboxylesterase 1 variant c.662A>G may decrease the bioactivation of oseltamivir in humans.
|
PLoS One
|
2017
|
0.75
|
|
12
|
Pharmacokinetic Interaction Among Telmisartan, Amlodipine, and Hydrochlorothiazide After a Single Oral Administration in Healthy Male Subjects.
|
Clin Ther
|
2019
|
0.75
|
|
13
|
Night-time gastric acid suppression by tegoprazan compared to vonoprazan or esomeprazole.
|
Br J Clin Pharmacol
|
2022
|
0.75
|
|
14
|
Population pharmacokinetics and dose-response relationship of levetiracetam in adult patients with epilepsy.
|
Epilepsy Res
|
2017
|
0.75
|
|
15
|
Pediatric patients undergoing hematopoietic stem cell transplantation can greatly benefit from a novel once-daily intravenous busulfan dosing nomogram.
|
Am J Hematol
|
2017
|
0.75
|
|
16
|
Safety, Tolerability, and Pharmacokinetic Characteristics of a Novel Nonopioid Analgesic, VVZ-149 Injections in Healthy Volunteers: A First-in-Class, First-in-Human Study.
|
J Clin Pharmacol
|
2017
|
0.75
|
|
17
|
Validated LC-MS/MS Assay for the Quantitative Determination of Fimasartan in Human Plasma: Application to Pharmacokinetic Studies.
|
J Chromatogr Sci
|
2015
|
0.75
|
|
18
|
Changes in Cardiac Function After a Single Intravenous Administration of CKD-712 in Healthy Male Volunteers.
|
Clin Drug Investig
|
2017
|
0.75
|